Finance

Lists
Why is EOLS up 4.88%?
Dive Deeper
EOLS:NASDAQ
Evolus Inc
$7.74
+4.88%
(+0.36) 1D
$7.74
0.00% (0.00)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EOLS...
Open
$7.37
High
$7.75
Low
$7.33
Mkt. cap
511.23M
Avg. vol.
873.89K
Volume
11.00
52-wk high
$9.31
52-wk low
$3.86
EPS
-$0.53
Beta
1.34
Shares outstanding
66.05M
No. of employees
353
Open
$7.37
High
$7.75
Low
$7.33
Mkt. cap
511.23M
Avg. vol.
873.89K
Volume
11.00
52-wk high
$9.31
52-wk low
$3.86
EPS
-$0.53
Beta
1.34
Shares outstanding
66.05M
No. of employees
353
News stories
From web sources and news partners
About Evolus Inc
CEODavid Moatazedi
Employees353
Founded2012
HeadquartersNewport Beach, California, United States
SectorPharmaceutical industry
Websiteevolus.com
Analyst ratings
Based on 5 analysts giving stock ratings to EOLS in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for EOLS in the last 3 months.
Highest
Current $7.74
$17.00 (+119.64%)
Average
$14.33 (+85.14%)
Lowest
$13.00 (+67.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Goodman
Leerink Partners
Buy
Maintained
-
-
09/16/2026
Uy Ear
Mizuho Securities
Buy
Maintained
$15.00
+93.8%
09/10/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$13.00
+68%
08/25/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$17.00
+119.6%
08/06/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/06/2026
Sam Eiber
BTIG
Buy
Reiterated
$13.00
+68%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-22.82%
0.14%
-14.59%
-9.58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps